New cancer drug enters first human tests for Tough-to-Treat tumors
Disease control
Recruiting now
This is a first-in-human study to test the safety and find the right dose of a new drug called BAL0891. It will be given alone and in combination with other cancer drugs to 260 adults with advanced solid tumors (like certain breast and stomach cancers) or a type of leukemia that …
Phase: PHASE1 • Sponsor: SillaJen, Inc. • Aim: Disease control
Last updated Apr 13, 2026 20:16 UTC